Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. - Wikidata - awgldk - TriplyDB

Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease.

Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease.

http://www.wikidata.org/entity/Q46703308

about

S-Propargyl-Cysteine, a Novel Hydrogen Sulfide Donor, Inhibits Inflammatory Hepcidin and Relieves Anemia of Inflammation by Inhibiting IL-6/STAT3 Pathway The impact of renal insufficiency and anaemia on survival in patients with cardiovascular disease: a cohort study Insights on aging and exceptional longevity from longitudinal data: novel findings from the Framingham Heart Study.Mild anemia is frequent and associated with micro- and macroangiopathies in patients with type 2 diabetes mellitus.Anemia is associated with the progression of white matter disease in older adults with high blood pressure: the cardiovascular health study Anaemia, haemoglobin level and cause-specific mortality in people with and without diabetes.Cardiovascular and Renal Links along the Cardiorenal Continuum Anemia and microvascular complications in patients with type 2 diabetes mellitus Association between ischemic stroke and iron-deficiency anemia: a population-based study.The relationship of initial transferrin saturation to cardiovascular parameters and outcomes in patients initiating dialysis Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease.Association of Estimated Glomerular Filtration Rate with Hemoglobin Level in Korean Adults: The 2010-2012 Korea National Health and Nutrition Examination Survey The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease.Associations between hemoglobin concentrations and the clinical characteristics of patients with type 2 diabetes.Urinary uromodulin, kidney function, and cardiovascular disease in elderly adults.Factors Contributing to Erythropoietin Hyporesponsiveness in Patients on Long-Term Continuous Ambulatory Peritoneal Dialysis: A Cross-Sectional Study Mortality rates in trials of subjects with type 2 diabetes.Association of Serum Erythropoietin With Cardiovascular Events, Kidney Function Decline, and Mortality: The Health Aging and Body Composition Study Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease.Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis.Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial.Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study.Can Serum Gdf-15 be Associated with Functional Iron Deficiency in Hemodialysis Patients?High doses of epoetin do not lower mortality and cardiovascular risk among elderly hemodialysis patients with diabetes.Anaemia and kidney dysfunction in Caribbean type 2 diabetic patients.Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients.Anemia, diabetes, and chronic kidney disease.Comparative study of intravenous iron versus intravenous ascorbic Acid for treatment of functional iron deficiency in patients under hemodialysis: a randomized clinical trial.Association between dietary iron, iron stores, and serum lipid profile in reproductive age women.Statins in patients with chronic kidney disease: why, who and when?How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: The "forgotten adjunct therapy": the link between ESA use and control of hyperparathyroidism in chronic kidney disease.A Comparative Study of the Hemoglobin-Maintaining Effects Between Epoetin-β Pegol and Darbepoetin-α in Patients with Chronic Kidney Disease During 3 Months Before Dialysis Initiation.Impact of individual intravenous iron preparations on the differentiation of monocytes towards macrophages and dendritic cells.Hospitalization and 1-year all-cause mortality in type 2 diabetic patients with chronic kidney disease at Stages 1 and 2: Effect of mild anemia.Association of Anemic Hypoxia and Increased Pulmonary Artery Systolic Pressure in Patients With Systemic Lupus Erythematosus.Similar Outcomes for Two Anemia Treatment Strategies among Elderly Hemodialysis Patients with Diabetes.Anemia: A significant cardiovascular mortality risk after ST-segment elevation myocardial infarction complicated by the comorbidities of hypertension and kidney disease.High Levels of Hemoglobin Promote Carotid Adventitial Vasa Vasorum Neoangiogenesis in Chronic Kidney Disease.[Self-reported diabetes in the elderly: prevalence, associated factors, and control practices].An Update on AMPK in Hydrogen Sulfide Pharmacology.

P2860

Q28554256-58845AF2-6F38-4547-AB68-5A62AE3E263D Q30883735-2FC63664-36E8-41B0-BBBA-8274929A75C9 Q31131033-ABDF0186-3E4D-4DAD-A087-5CADFDCB559C Q33585503-8FC746D1-6E21-4749-B259-FB2F770A8216 Q33961569-318926E0-41C7-4808-A1CA-9FFF98D9ECFE Q34372505-F8FEE7A7-B646-41D7-B933-E966EA5FC3FC Q34989544-79C0C298-F1CF-4624-98AA-FB14DF813115 Q35051107-2B779F1C-BDCD-42CC-8CD7-0485880670E1 Q35070656-79EF3E64-4ABA-4EC7-87D3-397518DF71D2 Q35088131-A65B714B-27D8-45F2-AB68-B9F50715393E Q35499717-BDC33956-0206-4141-901F-2A915D0FC109 Q36003320-48D88E51-4871-45BD-B88D-7181E69FAC21 Q36073903-057016C1-4B99-4792-90D2-788BC64587F0 Q36237952-4A94962D-7F00-46E8-A3C5-6AA7AB2291C0 Q36299917-13D8C05A-3956-4C40-827B-B4D4C78E1E05 Q36325731-99621B11-8F44-40B9-B126-680B2D7280B6 Q36366129-0AF91D51-E385-4A85-B961-D02786991E34 Q36423854-57B32714-1949-472C-A04E-AAB536C375CF Q36436893-D81A2320-7B7B-49D7-81EE-B067936042E2 Q36476556-AA223DB4-C531-403B-9DC7-8A4236F32026 Q36496447-460F58DB-0B3C-498E-B315-EBA6EFDA06C3 Q36633444-7DC42D49-EFBD-482E-BD6F-7C0DE7CD6F5C Q36679596-58EEAEB6-9D09-4D40-909B-9EE2EFCDAD3A Q36799806-9B899EDE-EB01-4078-8007-9BCA77C57FD6 Q36891269-A9E11F80-72CB-45E4-9DF5-CC6D014CF763 Q37000223-0A62C222-25F2-460F-AF5D-C2B1D987B53F Q37235968-17CAA226-F311-4BDF-9DDF-D345DCFDC8F5 Q37347851-071F1A53-3AA9-4815-A1EE-17C012C7FEDF Q37687900-2047D9BD-4A45-48B8-A146-B45AC57F15E9 Q37803236-FC187DC8-753D-4731-B74B-C09180F41015 Q38111803-87EC7497-4BBB-4AA7-A15F-6F96AB9DC9F2 Q38762167-CA98950E-F52E-4FBA-8C9D-E002A6CE28D8 Q40469488-BF5346AC-95F8-4219-9876-3799DF2E76D7 Q40872159-CF1EF028-37CF-4B87-9E17-EF3D3A368D32 Q40896042-041BC254-4526-47AD-9A5F-2AC762C1AD29 Q41123077-E0DA53C0-062A-482D-9771-330771B1A26D Q41153512-B12638F4-FFD7-44FE-B2A6-CE28E6DFFD7A Q41867898-5CCB222A-D608-4FBD-89C3-F4B9AD3FF0EC Q43818477-88DAD886-665E-4DD5-844B-CB9F3EA9D018 Q44418878-53B3FE10-2487-45B8-857F-9D794ECCC9B5

P2860

Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease.

http://www.wikidata.org/entity/Q46703308

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Anemia as a risk factor for ca ...... act of chronic kidney disease.

@en

Anemia as a risk factor for ca ...... act of chronic kidney disease.

@nl

type

label

Anemia as a risk factor for ca ...... act of chronic kidney disease.

@en

Anemia as a risk factor for ca ...... act of chronic kidney disease.

@nl

prefLabel

Anemia as a risk factor for ca ...... act of chronic kidney disease.

@en

Anemia as a risk factor for ca ...... act of chronic kidney disease.

@nl

P1433

Q46703308-4D88C095-A850-4DF2-B476-72ADC0FA1516

P1476

Q46703308-EA01529B-1FE0-4E8F-8BDC-66D7F0A6781A

P2093

Q46703308-12B3C75E-9134-465A-876D-54240606FB76

Q46703308-5C49045C-10BB-47C8-A1F7-8D5C9BBF31C9

Q46703308-698B8837-094C-41A6-BDCB-2A712AB9AB80

Q46703308-6F9978B0-F8E0-454D-8DDB-EB097DE8AAD7

Q46703308-88FA03FA-4F50-4ACA-B602-A9A77A040AF1

Q46703308-995D61F3-9085-4674-BAF2-1B6430FE222F

Q46703308-A717E49A-881A-47F4-B8DF-A869BF0D9BF1

Q46703308-A929BCDD-587E-4656-B86C-468E1DB05F6B

P304

Q46703308-425CF7C9-F6B8-48D2-AABF-BF8DF03504C3

P31

Q46703308-BDA66596-BB56-4B82-A9E5-611073801F34

P356

Q46703308-364F9188-F0FC-468A-8667-2417B35BCF89

P433

Q46703308-3CB1EEB3-D337-4D1B-BE7C-FDCD80FACDFC

P478

Q46703308-4F8B3ADB-AAD2-42E2-B799-91AFF89AED54

P577

Q46703308-DE452263-F7B7-4596-B3DB-4BFA2F6255C7

P698

Q46703308-DD75502C-98C7-4646-9D28-2BDC6D2617F6

P921

Q46703308-8884B41E-5C21-4FFD-A38F-1A6E495AEB8B

Q46703308-B6CC8294-CA51-4C7E-A248-3EC2210EBF2A

P356

P1433

Journal of the American Society of Nephrology

P1476

Anemia as a risk factor for ca ...... act of chronic kidney disease.

@en

P2093

Andrew S Levey

http://www.w3.org/2001/XMLSchema#string

Dan Pettitt

http://www.w3.org/2001/XMLSchema#string

Daniel E Weiner

http://www.w3.org/2001/XMLSchema#string

Deeb N Salem

http://www.w3.org/2001/XMLSchema#string

Hocine Tighiouart

http://www.w3.org/2001/XMLSchema#string

John Griffith

http://www.w3.org/2001/XMLSchema#string

Mark J Sarnak

http://www.w3.org/2001/XMLSchema#string

Panagiotis T Vlagopoulos

http://www.w3.org/2001/XMLSchema#string

P304

3403-3410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2005030226

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16162813

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease